Sequence Similarity Clusters for the Entities in PDB 3TCL

Entity #1 | Chains: A,H
CH04 Heavy Chain Fab protein, length: 237 (BLAST)
Sequence Similarity Cutoff Rank Chains in Cluster Cluster ID / Name
100 % 1 4 9257
95 % 1 4 9319
90 % 1 4 9225
70 % 338 1945 1
50 % 688 4012 1
40 % 688 4014 1
30 % 743 4750 1
Entity #2 | Chains: B,L
CH04 Light Chain Fab protein, length: 215 (BLAST)
Sequence Similarity Cutoff Rank Chains in Cluster Cluster ID / Name
100 % 1 2 18996
95 % 1 2 16578
90 % 89 585 3
70 % 279 1648 3
50 % 689 4012 1
40 % 689 4014 1
30 % 744 4750 1

Instructions

In the table for each entity, view a list of similar sequences by selecting the link associated with the percentage cutoff.



View more detailed documentation on the redundancy reduction and sequence clustering procedure used by RCSB PDB.


ACTION - (A) Select for download / view details OR (B) Select two chains for comparison
Rank PDB ID Entity ID Chains Description Details Taxonomy EC Number
1 4NZU 1 L 13PL heavy chain Fab 9606
2 4XCF 1 L 4E10 Fab light chain 9606
3 4XAW 1 L 4E10 Fab light chain 9606
4 2VXV 2 L HUMAN IGG ABT-325 9606
5 3M8O 1 L IMMUNOGLOBULIN A1 LIGHT CHAIN Fab fragment 9606
6 5I8C 2 B VRC34.01 Fab light chain 9606
7 3PP4 2 L GA101 Fab light chain 10090
8 4PTU 1 A Antibody pn132p2C05, light chain 9606
9 4HS6 2 A, L MRCT10.v362 Fab light chain 9606
10 4XC3 1 L 4E10 Fab light chain 9606
11 4XC1 1 L 4E10 FAB LIGHT CHAIN 9606
12 4CMH 3 C LIGHT CHAIN OF SAR650984-FAB FRAGMENT 10090
13 4NWU 2 L APE1551 Ab Fab light chain 9606
14 3HC4 2 L IMMUNOGLOBULIN IGG1 FAB, LIGHT CHAIN 9606
15 5E2W 1 L AT8 LIGHT CHAIN 10090
16 5E2V 1 L AT8 LIGHT CHAIN 10090
17 5CIN 2 L FAB 4E10 LIGHT CHAIN 9606
18 3QQ9 1 C, L 101F LIGHT CHAIN 10090
19 5I1K 1 L FAB LIGHT CHAIN 9606
20 4JDV 2 B, L Fab light chain NIH45-46 Germ-line Light CHAIN, IG Kappa 9606
21 3QRG 1 L Fab light chain 9606
22 3NCJ 1 L Fab15 Mut8 light chain 9606
23 3HC3 2 L IMMUNOGLOBULIN IGG1 FAB, HEAVY CHAIN 9606
24 4NWT 1 L APE1531 Ab Fab light chain 9606
25 3NA9 1 L Fab15 light chain 9606
26 1NGZ 1 A Germline Metal Chelatase Catalytic Antibody, Light chain germline Fab fragment 10090
27 4LRI 1 A, B MSL-109 Light Chain 9606
28 4JN2 1 A, L anti dabigatran Fab 10090
29 4XBE 1 L 4E10 FAB LIGHT CHAIN 9606
30 4HHA 1 A Fab KE5 Fab fragment KE5 9606
31 3NAA 1 L Fab15 Mut5 light chain 9606
32 4XVT 3 L 45-VRC01.H01+07.O-863513/45-VRC01.L01+07.O-110653 (VRC07_1995) Light chain 9606
33 4PUB 2 L DX-2930 LIGHT CHAIN 9606
34 3OAZ 2 K, L Fab 2G12, light chain 9606
35 4YGV 2 B, L aDabi-Fab2a light chain 9606
36 3EO0 1 A, C GC-1008 Fab Light Chain 10090
37 5CIL 2 L FAB 4E10 LIGHT CHAIN 9606
38 4JHA 2 L D25 light chain 9606
39 4PTT 1 A Antibody pn132p2C05, light chain 9606
40 4DGV 2 L HCV1 Light Chain 9606
41 5D6C 1 A, L 4497 antibody IgK (VL and CL) 9606
42 3IU4 2 L chP3 Fab light chain 10090
43 3P0Y 3 L Fab DL11 light chain 9606
44 4HH9 1 A, C Fab KE5, light chain KE5 Light chain 9606
45 3NAC 1 L Fab15 Mut7 light chain 9606
46 4YHO 2 L aDabi-Fab3 light chain 9606
47 4DGY 2 L HCV1 Light Chain 9606
48 3MXW 2 L 5E1 light chain 9606
49 2V7N 1 A, C, E, G IMMUNOGLOBULIN LIGHT CHAIN SYNTHETIC GENE, DERIVED FROM PHAGE DISPLAY OF THE HUMAN COMBINATORIAL ANTIBODY LIBRARY (HUCAL) FAB FRAGMENT, RESIDUES 1-255 32630
50 3EO9 1 L Efalizumab Fab fragment, light chain 9606
51 2HWZ 1 L Immunoglobulin Fab light chain Humanized mouse antibody MEDI-493 Anti-respiratory syncytial virus antibody 10090
52 1L7I 1 L chimera of Fab2C4: "humanized" murine monoclonal antibody The chimera consists of the human Ig and the original murine sequence light chain (residues 1-214) 9606
53 1JPT 1 L immunoglobulin Fab D3h44, light chain Fab fragment 9606
54 2FX7 1 L Fab 4E10 Light Chain 9606
55 4DTG 1 L Humanized recombinant FAB fragment, FAB 2021, of a murine antibody, light chain 9606
56 5CSZ 2 B, L GANTENERUMAB FAB FRAGMENT LIGHT CHAIN FAB 9606
57 5I18 1 L FAB LIGHT CHAIN 9606
58 4JN1 2 L anti-dabigatran Fab1, light chain 10090
59 3SOB 1 L antibody light chain 9606
60 4G6M 3 L light chain of gevokizumab antibody binding fragment 10090
61 5DR5 2 L AbD09097 Fab light chain 9606
62 4KQ3 1 L CNTO3186 light chain Fab 9606
63 2VXQ 3 L FAB L CHAIN OF THE FAB FRAGMENT COMPOSED OF THE IGE VARIABLE DOMAIN AND IGG CONSTANT DOMAIN 9606
64 4I77 2 L Lebrikizumab light chain Fab 9606
65 4HJG 1 A Trastuzumab light chain 9606
66 3HC0 2 B, L IMMUNOGLOBULIN IGG1 FAB, HEAVY CHAIN 9606
67 3FN0 1 L Fab Z13e1 light chain 9606
68 4YHI 2 B, L aDabi-Fab2a light chain 9606
69 3MXV 1 L fab fragment of anti-Shh 5E1 mouse/human chimera, light chain 10090
70 5IFA 2 L VRC01c-HuGL2 Fab light chain 9606
71 4G6K 2 L light chain of gevokizumab antibody binding fragment 10090
72 4MAU 1 L C2244 light chain SEE REMARK 999 10090
73 1OP3 1 K, L FAB 2G12, light chain light chain 9606
74 1JPS 1 L immunoglobulin Fab D3H44, light chain Fab fragment 9606
75 4LKX 2 B Fab fragment light chain 9606
76 5JW5 2 B, L MEDI8852 Light chain 9606
77 3QWO 1 B, L motavizumab light chain 10090
78 4IOI 1 A Trastuzumab light chain 9606
79 1N7M 1 H Germline Metal Chelatase Catalytic Antibody, chain H 10090
80 3I9G 2 L Sonepcizumab antibody Fab fragment, light chain Fab Fragment 10090
81 5I16 1 A, L FAB LIGHT CHAIN 9606
82 5F9O 3 L CH235.09 Light chain 9606
83 4RBP 1 K, L Fab 2G12 light chain 9606
84 4XVS 2 L 45-VRC01.H01+07.O-863513/45-VRC01.L01+07.O-110653 Light chain 9606
85 4FQL 2 L monoclonal antibody CR8033 light chain Fab 9606
86 1NGX 1 A, L Germline Metal Chelatase Catalytic Antibody, Light chain germline Fab fragment 10090
87 3OAY 1 K, L Fab 2G12, light chain 9606
88 5K9J 2 L 56.a.09 light chain 9606
89 3TCL 2 B, L CH04 Light Chain Fab 9606
90 4OJF 2 L Humanised 3D6 Fab Light Chain 10090
91 5F7E 2 L Fab light chain 9606
92 1T3F 1 A Huzaf antibody light chain The source is engineered human constant and framework regions with CDRs from mouse 9606
93 5FHA 2 L Antibody 114 Fab light chain 9606
94 4X7S 2 L Ig kappa chain C region residues 23-236 9606
95 4X0K 2 B, L Fab fragment light chain 9606
96 1S3K 1 L HU3S193 Fab fragment, light chain murine complementarity determining regions grafted onto human framework and constant sequences 10090
97 5E8E 1 A IGA FAB LIGHT CHAIN 9606
98 2HFF 1 A, L CB2 Fab, light chain 9606
99 4M7K 1 L 10H10 light chain SEE REMARK 999 10090
100 1VGE 1 L TR1.9 FAB FAB FRAGMENT OF A HUMAN IGG1 KAPPA AUTOANTIBODY 9606
101 5I1L 1 A, L FAB LIGHT CHAIN 9606
102 3L5X 1 L H2L6 LIGHT CHAIN 9606
103 2NXY 3 C ANTIBODY 17B, LIGHT CHAIN ANTIGEN-BINDING FRAGMENT, FAB 9606
104 2R8S 2 L Fab light chain 10090
105 4HKZ 1 A Trastuzumab light chain 9606
106 5CHN 2 B, L Antibody 5M16 Fab Light Chain 9606
107 3SO3 2 B A11 FAB light chain 9606
108 3IDG 1 A 2F5 Fab light chain 9606
109 3OAU 2 L Fab 2G12, light chain 9606
110 4WY7 2 L Fab 4E10Light chain 9606
111 4ZYK 2 B, L AM14 light chain 9606
112 5E94 1 A, C Antibody Fab fragment light chain 10090
113 5FB8 1 A Anti-IL-16 antibody 14.1 Fab domain Kappa Chain 10090
114 3U0W 2 L Fab Light Chain, Ig kappa chain C region chimera of Fab Light Chain from mouse, Ig kappa chain C region from human 10090
115 2O5X 1 L chimeric antibody Fab 1E9-DB3 light chain 10090
116 4HIE 1 A Fab 023.102 9606
117 4LEX 1 L FAB HEAVY CHAIN 10090
118 3QEG 2 L Fab fragment of human anti-HIV antibody N12-i2, light chain Fab light chain 9606
119 1CE1 1 L PROTEIN (CAMPATH-1H:LIGHT CHAIN) FAB 9606
120 2NY2 3 C ANTIBODY 17B, LIGHT CHAIN ANTIGEN-BINDING FRAGMENT, FAB 9606
121 4KMT 1 L light chain O12/KAPPA Fab 9606
122 3NZH 1 L 5F6 LIGHT CHAIN 10090
123 1RHH 1 A, C Fab X5, light chain 9606
124 1TJG 1 L FAB 2F5 Light Chain 9606
125 4JPI 2 B, L Putative VRC01 germline Fab light chain 9606
126 4XTR 3 D, F Antibody Light chain 32630
127 1RZ7 1 L Fab 48d light chain 9606
128 1RZG 2 B, D Fab 412d heavy chain 9606
129 5EA0 2 L Light chain of antibody 7968 Fab fragment 9606
130 3PGF 3 L SAB Light Chain 9606
131 1IQD 1 A HUMAN MONOCLONAL BO2C11 FAB LIGHT CHAIN 9606
132 2NY4 3 C ANTIBODY 17B, LIGHT CHAIN ANTIGEN-BINDING FRAGMENT, FAB 9606
133 4YHL 2 L aDabi-Fab2b light chain 9606
134 2NY3 3 C ANTIBODY 17B, LIGHT CHAIN ANTIGEN-BINDING FRAGMENT, FAB 9606
135 5I1A 1 A, L CNTO388 LIGHT CHAIN 9606
136 2QQN 3 L Antibody light chain 9606
137 3L5W 1 A, L C836 LIGHT CHAIN CHIMERIC MOLECULE OF MOUSE VARIABLE DOMAIN AND HUMAN CONSTANT DOMAIN 10090
138 2NY1 3 C ANTIBODY 17B, LIGHT CHAIN ANTIGEN-BINDING FRAGMENT, FAB 9606
139 4OGY 3 L, N DX-2930 LIGHT CHAIN 9606
140 4YHM 2 L aDabi-Fab2b light chain 9606
141 3X3F 2 L Light chain of KMTR2 9606
142 2CMR 3 L D5 9606
143 4R4B 1 A, C, E, L FAB 2.2C LIGHT CHAIN 9606
144 5CZX 3 D, L 20358 Fab light chain 9606
145 3GRW 2 L Fab light chain 9606
146 5I1D 1 A, L FAB LIGHT CHAIN 9606
147 3QCU 2 L, M LT3015 antibody Fab fragment, light chain 9606
148 2NXZ 3 C ANTIBODY 17B, LIGHT CHAIN ANTIGEN-BINDING FRAGMENT, FAB 9606
149 1UJ3 1 A IgG Fab light chain anti-tissue-factor antibody hATR-5 Fab 9606
150 4HIX 2 L Humanized 3D6 Fab light chain 10090
151 4LKC 1 A Fab fragment of PCSK9 antibody 9606
152 4OM1 3 L Antigen binding fragment of light chain: Antibody VRC01 9606
153 4KZD 2 L BL3-6 Fab antibody, light chain 10090
154 4HCR 2 L, N PF-547659 light chain 9606
155 4CNI 2 B, L OLOKIZUMAB LIGHT CHAIN, FAB PORTION FAB PORTION 9606
156 1TJH 1 L anti-HIV-1 antibody 2F5 Light Chain 9606
157 4HIH 1 A, C Fab 023.102 9606
158 4YHK 2 L aDabi-Fab2a light chain 9606
159 4XH2 2 B, D, F, I, K, L Fab Light Chain 9606
160 3DRQ 1 A 2F5 Fab' light chain 9606
161 5IES 2 L VRC01cHuGL2 Fab light chain 9606
162 4UV7 3 L GC1118A 9606
163 1TJI 1 L anti-HIV-1 antibody 2F5 Light Chain 9606
164 3QNX 1 A Fab fragment of IMMUNOGLOBULIN A1 LIGHT CHAIN 9606
165 4OLZ 3 L Antigen binding fragment of light chain: Antibody VRC01 9606
166 3D0V 1 A 2F5 Fab heavy chain 9606
167 3S34 1 L 1121B Fab light chain 10090
168 3MOD 2 L ANTI-HIV-1 ANTIBODY 2F5 LIGHT CHAIN 9606
169 5E2T 1 L AT8 LIGHT CHAIN 10090
170 2F5B 1 L PROTEIN (ANTIBODY 2F5 (LIGHT CHAIN)) FAB' 9606
171 1U8I 1 A ANTIBODY 2F5 (LIGHT CHAIN) 9606
172 2AJ3 1 A, C, E Fab m18, Light Chain 9606
173 3IDI 1 A 2F5 Fab light chain 9606
174 3PNW 1 A, D, G, J, M, P, S, V FAB light chain 32630
175 3QO0 1 A Fab fragment of IMMUNOGLOBULIN G1 LIGHT CHAIN 9606
176 4NRX 3 B, E, L m66 Light Chain 9606
177 3O2D 1 L ibalizumab light chain 10090
178 3HI6 3 L, Y light chain of Fab fragment of AL-57 against alpha L I domain 9606
179 4ZFG 3 L Fragment antigen binding 5A12 light chain 9606
180 2R0L 1 L antibody light chain 32630
181 1DN0 1 A, C IGM-KAPPA COLD AGGLUTININ (LIGHT CHAIN) FAB FRAGMENT 9606
182 3GIZ 1 L Fab fragment of anti-CD20 antibody Ofatumumab, light chain 9606
183 3QNZ 1 A Fab fragment of IMMUNOGLOBULIN G1 LIGHT CHAIN 9606
184 3Q1S 1 L Z13e1 Fab light chain 9606
185 1U8H 1 A ANTIBODY 2F5 (LIGHT CHAIN) 9606
186 3FO2 1 A, L Catalytic antibody Fab 13G5 kappa light chain chimera FUSION PROTEIN. THE VARIABLE DOMAIN (RESIDUES 1-107) IS FROM A MURINE SOURCE AND THE CONSTANT DOMAIN (RESIDUES 108-214) IS FROM A HUMAN SOURCE 10090
187 5F96 3 L LIGHT CHAIN OF ANTIBODY CH235.12 9606
188 2F5A 1 L PROTEIN (ANTIBODY 2F5 (LIGHT CHAIN)) FAB' 9606
189 4OLU 3 L Antigen binding fragment of light chain: Antibody VRC01 9606
190 3KR3 3 L antibody-Fab (light chain) 9606
191 5DK3 1 A, F Light Chain 9606
192 4OLX 3 L Antigen binding fragment of light chain: Antibody VRC01 9606
193 2NY0 3 C ANTIBODY 17B, LIGHT CHAIN ANTIGEN-BINDING FRAGMENT, FAB 9606
194 4YHN 2 B, L aDabi-Fab3 light chain 9606
195 3MOA 2 L ANTI-HIV-1 ANTIBODY 2F5 LIGHT CHAIN 9606
196 3QO1 1 A Fab fragment of IMMUNOGLOBULIN G1 LIGHT CHAIN 9606
197 2PR4 1 L nmAb 2F5 Fab' Heavy Chain 9606
198 4D9Q 2 D, L Anti-Factor D, light chain 9606
199 1A4J 1 A, L IMMUNOGLOBULIN, DIELS ALDER CATALYTIC ANTIBODY (LIGHT CHAIN) FAB 10090
200 3QNY 1 A, C FAB FRAGMENT OF IMMUNOGLOBULIN A1 LIGHT CHAIN 9606
201 1YYM 2 L, Q antibody 17b light chain ANTIGEN-BINDING FRAGMENT, FAB 9606
202 1FL5 1 A, L ANTIBODY GERMLINE PRECURSOR TO ANTIBODY 28B4 LIGHT CHAIN (CHAINS L AND A) 10090
203 2O5Z 1 L chimeric antibody Fab 1E9-DB3 light chain 10090
204 4OM0 3 L Antigen binding fragment of light chain: Antibody VRC01 9606
205 3AAZ 2 B, L Humanized recombinant Fab fragment of a murine; antibody 9606
206 4QXG 2 L Fab, light chain, IgG1 Fab, light chain 9606
207 3O2V 1 L Chimeric antibody Fab 1E9, light chain 10090
208 2I5Y 2 L, Q Antibody 17B Light chain ANTIGEN-BINDING FRAGMENT, FAB 9606
209 2FX9 1 L, M Fab 4E10 Light Chain 9606
210 3C08 1 L Matuzumab Fab Light chain Human/mouse chimeric derivative of mouse monoclonal antibody 425 10090
211 1BZ7 1 A PROTEIN (ANTIBODY R24 (LIGHT CHAIN)) FAB 10090
212 1TZG 1 L, M Fab 4E10 light chain 9606
213 3W9D 2 B, D Antibody Fab light chain 9606
214 1U95 1 A ANTIBODY 2F5 (LIGHT CHAIN) 9606
215 4NRZ 2 B, L M66.6 LIGHT CHAIN Fab Light Chain 9606
216 3BN9 2 C, E E2 Fab Light Chain 9606
217 4HWE 2 L Fab light chain light chain 9606
218 1U8K 1 A ANTIBODY 2F5 (LIGHT CHAIN) 9606
219 3L95 1 A, L anti-NRR1 fab fragment light chain 9606
220 4OGX 3 L DX-2930 LIGHT CHAIN 9606
221 3W9E 3 B Antibody Fab light chain 9606
222 3UTZ 1 A, D, E Metalloproteinase 10090
223 5E2U 1 L AT8 LIGHT CHAIN 10090
224 1OM3 1 L, M FAB 2G12, light chain light chain 9606
225 4KZE 2 L BL3-6 Fab antibody, light chain 10090
226 4HIJ 1 A, C Fab 023.102 light chain 9606
227 3FO1 1 A, L Catalytic antibody Fab 13G5 kappa light chain chimera FUSION PROTEIN. THE VARIABLE DOMAIN (RESIDUES 1-107) IS FROM A MURINE SOURCE AND THE CONSTANT DOMAIN (RESIDUES 108-214) IS FROM A HUMAN SOURCE 10090
228 4XVU 3 D, F, J, L Antibody light chain 32630
229 3QCT 2 L LT3015 antibody Fab fragment, light chain 9606
230 3EYF 1 A, C 8f9 Fab 9606
231 3NAB 1 L Fab15 Mut6 light chain 9606
232 3IDN 1 A 2F5 Fab light chain 9606
233 5I1C 1 L FAB LIGHT CHAIN 9606
234 1RZ8 1 A, C Fab 17b light chain 9606
235 4WV1 3 A, D Fab light chain 9606
236 4OLY 3 L Antigen binding fragment of light chain: Antibody VRC01 9606
237 4FNL 2 L, M Antibody C05, Light Chain 9606
238 4UB0 2 L IgG1, light chain 9606
239 1U92 1 A ANTIBODY 2F5 (LIGHT CHAIN) 9606
240 1FVD 1 A, C IGG1-KAPPA 4D5 FAB (LIGHT CHAIN) 9606
241 1BJ1 1 J, L FAB FRAGMENT HUMANIZED VERSION OF A MONOCLONAL MURINE ANTI-VEGF ANTIBODY 10090
242 1U91 1 A ANTIBODY 2F5 (LIGHT CHAIN) 9606
243 5I1H 1 L FAB LIGHT CHAIN 9606
244 2FX8 1 L, M, N, O Fab 4E10 Light Chain 9606
245 1NGY 1 A Mature Metal Chelatase Catalytic Antibody, Light chain Fab fragment 10090
246 5I1J 1 L FAB LIGHT CHAIN 9606
247 3IDX 3 L Fab b13 light chain 9606
248 1U8Q 1 A ANTIBODY 2F5 (LIGHT CHAIN) 9606
249 5CIP 2 B, L FAB 4E10 LIGHT CHAIN 9606
250 3IDJ 1 A 2F5 Fab light chain 9606
251 3IDM 1 A 2F5 Fab light chain 9606
252 1U8J 1 A ANTIBODY 2F5 (LIGHT CHAIN) 9606
253 1ZLV 1 K, L FAB 2G12, light chain FAB, Light Chain 9606
254 5IF0 2 B, L VRC01c-HuGL2 Fab light chain 9606
255 4K94 1 L Fab19 heavy chain 9606
256 1ZLS 1 L FAB 2G12, light chain FAB, Light Chain 9606
257 1I7Z 1 A, C CHIMERA OF IG KAPPA CHAIN: HUMAN CONSTANT REGION AND MOUSE VARIABLE REGION THE CHIMERA CONSISTS OF RESIDUES 1-108 OF MOUSE PORTION AND 109-214 OF HUMAN PORTION OF IG KAPPA CHAIN. 10090
258 3D0L 1 A 2F5 heavy chain 9606
259 4JPK 2 L Putative VRC01 germline precursor Fab light chain 9606
260 4ZD3 2 L 679-14-14E06 Fab fragment light chain 9606
261 3FCT 1 A, C PROTEIN (METAL CHELATASE CATALYTIC ANTIBODY) CHIMERIC FAB FRAGMENT FAB FRAGMENT 9606
262 3X3G 2 L Light chain of KMTR2 9606
263 5E08 2 L Fab Light Chain 9606
264 2P8L 1 A nmAb 2F5, light chain 9606
265 1CZ8 2 L, X LIGHT CHAIN OF NEUTRALIZING ANTIBODY MUTATED FORM OF A HUMANIZED MURINE ANTIBODY LIGHT CHAIN FAB FRAGMENT 10090
266 4XAK 3 E, L Light chain of neutralizing antibody m336 9606
267 1A4K 1 A, L ANTIBODY FAB FAB 10090
268 3HR5 1 A, L, P, Q Fab h47H4 light chain 10090
269 2I60 2 L, Q ANTIBODY 17B LIGHT CHAIN ANTIGEN-BINDING FRAGMENT, FAB 9606
270 4NGH 1 L FAB LIGHT CHAIN 9606
271 4EDW 2 L tanezumab Fab light chain 9606
272 1UCB 1 L CHIMERIC HUMAN/MOUSE IGG FAB FRAGMENT BR96 MOUSE VH AND VL DOMAINS, HUMAN CL KAPPA AND CH1 IGG1 DOMAINS 9606
273 1FVE 1 A, C IGG1-KAPPA 4D5 FAB (LIGHT CHAIN) 9606
274 2NY5 3 L ANTIBODY 17B, LIGHT CHAIN ANTIGEN-BINDING FRAGMENT, FAB 9606
275 4NM4 1 L, M Antibody CR8043, Light Chain 9606
276 4LST 3 L LIGHT CHAIN OF ANTIBODY VRC01 9606
277 3U7Y 3 L NIH45-46 light chain, Ig kappa chain C region 9606
278 1U8M 1 A ANTIBODY 2F5 (LIGHT CHAIN) 9606
279 4D9R 2 D, L Fab light chain 9606
280 3U7W 2 L Light chain, Ig kappa chain C region 9606
281 2H9G 1 A, L Fab BdF1, light chain Fab fragment 9606
282 4G7V 2 L fragment antibody light chain 9606
283 4HFW 1 A, L 6-26 Fab Light chain 9606
284 3L7E 1 A, L C836 LIGHT CHAIN CHIMERIC MOLECULE OF MOUSE VARIABLE DOMAIN AND HUMAN CONSTANT DOMAIN 10090
285 2XRA 3 L HK20, HUMAN MONOCLONAL ANTIBODY LIGHT CHAIN 9606
286 4LIQ 3 L Fab fragment RG7155 light chain Humanized Version of a monoclonal murine. 10090
287 4S1Q 3 L Fab of VRC01 light chain Fab of VRC01 light chain 9606
288 4KQ4 1 L CNTO7357 light chain Fab (mouse variable domain, human constant domain) 10090
289 3INU 2 L, N KZ52 antibody fragment light chain 9606
290 3LEV 2 L 2F5 ANTIBODY LIGHT CHAIN 9606
291 4OLV 3 L Antigen binding fragment of light chain: Antibody VRC01 9606
292 1DFB 1 L IGG1-KAPPA 3D6 FAB (LIGHT CHAIN) 9606
293 2EH7 1 L HUMANIZED KR127 FAB, LIGHT CHAIN 10090
294 1RZJ 3 L ANTIBODY 17B, LIGHT CHAIN FAB 9606
295 4HII 1 A, C Fab 023.102 light chain 9606
296 2EH8 1 L HUMANIZED KR127 FAB, LIGHT CHAIN 10090
297 1AD0 1 A, C ANTIBODY A5B7 (LIGHT CHAIN) FAB FRAGMENT 9606
298 4DN3 1 L CNTO888 LIGHT CHAIN 9606
299 4U6V 2 L, M Fab, antigen binding fragment, light chain 9606
300 4LSS 3 L LIGHT CHAIN OF ANTIBODY VRC01 with N72T mutation 9606
301 2XA8 2 L OMALIZUMAB LIGHT CHAIN 9606
302 3MOB 2 L ANTI-HIV-1 ANTIBODY 2F5 LIGHT CHAIN 9606
303 3EYV 1 A, L hu3S193 Fab, light chain 10090
304 1GC1 3 L ANTIBODY 17B MONOCLONAL ANTIBODY 17B BINDS TO A CD4-INDUCED SITE ON GP120 ANTIGEN-BINDING FRAGMENT, FAB 9606
305 3PP3 2 K, L GA101 Fab light chain 10090
306 3BDY 2 L Fab Fragment -Light Chain 9606
307 5I8E 2 B, D VRC34.01 Fab light chain 9606
308 3FZU 1 D, L immunoglobulin IgG1 Fab, light chain 9606
309 1G9M 3 L ANTIBODY 17B, LIGHT CHAIN ANTIGEN-BINDING FRAGMENT, FAB 9606
310 3K2U 4 L Antibody, Fab fragment, Light Chain 9606
311 1U8N 1 A ANTIBODY 2F5 (LIGHT CHAIN) 9606
312 4HWB 3 L Fab light chain 9606
313 1U93 1 A ANTIBODY 2F5 (LIGHT CHAIN) 9606
314 3O2W 1 L Chimeric antibody Fab 1E9, light chain 10090
315 1PG7 2 L, M humanized antibody D3H44 antigen-binding fragment 10090
316 2HFG 1 L CB3s Fab light chain (kappa) 9606
317 3GKW 2 L Light chain of the antibody Nimotuzumab 9606
318 3JWD 3 L, O FAB 48D LIGHT CHAIN 9606
319 4JQI 3 L Fab30 light chain 10090
320 3SKJ 1 L, M Antibody, light chain 9606
321 3U30 2 B, E Light chain Fab 9606
322 3QCV 2 L, M LT3015 antibody Fab fragment, light chain 9606
323 3U0T 1 A, C ponezumab LC Fab 9606
324 5HYS 2 B, D, F, L Uncharacterized protein 9606
325 3FO0 1 L Catalytic antibody Fab 13G5 kappa light chain chimera FUSION PROTEIN. THE VARIABLE DOMAIN (RESIDUES 1-107) IS FROM A MURINE SOURCE AND THE CONSTANT DOMAIN (RESIDUES 108-214) IS FROM A HUMAN SOURCE 10090
326 3L7F 1 A, D, L H2L6 LIGHT CHAIN 9606
327 5I15 1 L FAB LIGHT CHAIN 9606
328 2FJF 1 A, C, E, G, J, L, M, O, Q, S, U, W Light Chain of a VEGF binding Antibody 9606
329 5I1E 1 L FAB LIGHT CHAIN 9606
330 2NYY 2 C CR1 monoclonal antibody light chain 9606
331 2GCY 1 A huC25 fab fragment light chain 10090
332 4JLR 2 B, L Motavizumab Fab light chain 9606
333 2QQK 3 L Antibody Light Chain 9606
334 4J1U 1 A, C, E antibody 93F3 Light chain 10090
335 2PW2 1 A 2F5 Fab' heavy chain 9606
336 3NGB 3 C, F, K, L Antigen binding fragment of light chain: Antibody VRC01 9606
337 4RRP 1 A, B, C, D, E, F Fab antibody, light chain 9606
338 4XGZ 2 B, D, F, I, K, L, N, P, R, T, V, X FAB LIGHT CHAIN 9606
339 1N8Z 1 A Herceptin Fab (antibody) - light chain 10090
340 2PW1 1 A 2F5 Fab fragment heavy chain 9606
341 4OAW 1 A, C Light chain of Fab fragment of anti-HIV1 gp120 V2 mAb 2158 9606
342 4KXZ 3 I, L, M, P GC1008 Light Chain 9606
343 1TZH 2 A, L Fab YADS1 Light Chain 10090
344 4XML 1 L Light chain of HIV-1 gp120 V3-specific human monoclonal antibody 2424 9606
345 4JZJ 3 B, L Fab Light Chain 10090
346 5BMF 2 L Fab fragment light chain 9606
347 5BO1 3 L, M Fab light chain 9606
348 4M6O 1 L CNTO7309 light chain 9606
349 3QEH 2 B, D, F, H Fab fragment of human anti-HIV-1 Env antibody N12-i15,light chain Fab light chain 9606
350 4OLW 3 L Antigen binding fragment of light chain: Antibody VRC01 9606
351 4DVR 2 L Fab 48d Light chain 9606
352 3EYQ 1 C M2J5 Fab 9606
353 4XWO 3 D, F, J, L, P, R, V, X Antibody light chain 32630
354 2O5Y 1 L chimeric antibody Fab 1E9-DB3 light chain 10090
355 4ZFF 2 B, L Fragment antigen binding (Fab) 5A12 Light chain 9606
356 3HI5 2 L light chain of Fab fragment of AL-57 against alpha L I domain 9606
357 4XXD 1 A, D Fab Light Chain 9606
358 5F9W 3 C, L Light chain of CH235-lineage antibody CH235 9606
359 1CLY 1 L IGG FAB (HUMAN IGG1, KAPPA) COMPLEXED WITH LEWIS Y NONOATE METHYL ESTER CHIMERIC FRAGMENT (BR96) 9606
360 4XBG 1 B, D, F, I, K, L 4E10 Fab light chain 9606
361 1YYL 2 L, Q antibody 17b light chain ANTIGEN-BINDING FRAGMENT, FAB 9606
362 1U8L 1 A ANTIBODY 2F5 (LIGHT CHAIN) 9606
363 2NY6 3 C ANTIBODY 17B, LIGHT CHAIN ANTIGEN-BINDING FRAGMENT, FAB 9606
364 5FUZ 2 L 645 FAB, LIGHT CHAIN 9606
365 3DVG 1 A Human IgG1 fab fragment light chain 9606
366 4HS8 3 L antibody hu5B3.v2 Fab light chain 9606
367 2AGJ 1 L Yvo Fab, Light Chain 9606
368 4JKP 3 L Light chain of antibody 45-46M2 9606
369 3EYO 1 A, C 8f9 Fab 9606
370 1B6D 1 A, B IMMUNOGLOBULIN IMMUNOGLOBULIN LIGHT-CHAIN DIMER 9606
371 5BZD 1 A, C 5G8 HIV Antibody light chain 9606
372 3NFS 1 L Heavy chain of Fab fragment of daclizumab 9606
373 3B2U 1 D, G, K, L, O, R, U, X IMC-11F8 Fab Light chain 9606
374 4DN4 1 L CNTO888 LIGHT CHAIN 9606
375 2FGW 1 L H52 FAB (LIGHT CHAIN) 9606
376 1B2W 1 L PROTEIN (ANTIBODY (LIGHT CHAIN)) V DOMAIN AND C DOMAIN 10090
377 2FJG 2 A, L Fab light chain 9606
378 4DKF 3 L, M FAb2 Light Chain 9606
379 1UWE 2 L, U, X ANTIBODY 14D9 FAB LIGHT CHAIN, RESIDUES 1-212 10090
380 1HEZ 1 A, C KAPPA LIGHT CHAIN OF IG 1-214 9606
381 1IT9 1 L HUMANIZED ANTIBODY HFE7A, LIGHT CHAIN FAB FRAGMENT 10090
382 3EFD 1 L FabL 10090
383 4LF3 1 A, D Fab heavy chain 10090
384 5K59 4 F, L Fab light chain 9606
385 1UWG 2 L, X ANTIBODY 14D9 CATALYTIC ANTIBODY 19C9 FAB LIGHT CHAIN, RESIDUES 1-213 10090
386 5KN5 2 B, E Epiregulin Antibody LY3016859 Fab Light Chain 9606
387 4XCN 1 B, D, F, I, K, L 4E10 Fab light chain 9606
388 4LEO 2 B RG7116 Fab light chain 10090
389 4G7Y 2 L Fragment antibody light chain 9606
390 4PY8 4 J antibody 3.1 light chain Fab 9606
391 3SDY 4 L Antibody CR8020, Light Chain 9606
392 3DVN 1 A, L Human IgG1 fab fragment light chain 9606
393 3IXT 1 B, L Motavizumab Fab light chain 10090
394 2P8M 1 A nmAb 2F5, light chain 9606
395 4NP4 3 L, M bezlotoxumab light chain 9606
396 3UC0 3 L, M Light chain, monoclonal antibody 5H2 Fab 9598
397 4XCE 1 B, D, L 4E10 Fab light chain 9606
398 5I1I 1 L FAB LIGHT CHAIN 9606
399 4NNP 3 L, Y Light chain of antagonistic fab fragment 9606
400 4ERS 1 L Fab light chain 9606
401 1DEE 1 A, C, E IGM RF 2A2 FAB LIGHT CHAIN 9606
402 4MWF 2 B, L Fab AR3C light chain 9606
403 2WUC 5 L FAB FRAGMENT FAB40.DELTATRP LIGHT CHAIN 9606
404 3SQO 3 L J16 Light chain 9606
405 4K3J 4 L Onartuzumab Fab light chain 10090
406 4PS4 1 L M1295 LIGHT CHAIN 9606
407 3HI1 2 A, L F105 Light Chain 9606
408 4PY7 2 B, J antibody 3.1 light chain Fab 9606
409 4K8R 3 C Fab1, light chain 9606
410 1RZK 3 L ANTIBODY 17B, LIGHT CHAIN FAB 9606
411 1ZLU 1 K, L FAB 2G12, light chain FAB, Light Chain 9606
412 1G9N 3 L ANTIBODY 17B, LIGHT CHAIN ANTIGEN-BINDING FRAGMENT, FAB 9606
413 1TZI 1 A Fab YADS2 Light Chain 10090
414 1QLR 1 A, C IGM KAPPA CHAIN V-III (KAU COLD AGGLUTININ) FAB FRAGMENT 9606
415 4KUZ 1 L antibody 4A5 light chain Fab (mouse variable domain, human constant domain) 10090
416 4X7T 2 B, L Omalizumab-Fab Light chain 9606
417 4YK4 1 B, Y 641 I-9 VLCL antibody 9606
418 2QSC 1 L Fab F425-B4e8, Light chain Light chain 9606
419 1MHP 3 L, Y FAB FRAGMENT, light chain 10090
420 4N9G 2 B, F, L, N Antibody 17HD9, Light Chain 9544
421 1FL6 1 A, L ANTIBODY GERMLINE PRECURSOR TO 28B4 LIGHT CHAIN (CHAINS L AND A) 10090
422 3R1G 3 L FAB of YW412.8.31 antibody light chain 9606
423 5I1G 1 L FAB LIGHT CHAIN 9606
424 2QQL 3 L Antibody Light Chain 9606
425 2P8P 1 A nmAb 2F5, light chain 9606
426 4XCC 1 L 4E10 Fab light chain 9606
427 4MXV 2 E, L, X anti-Lymphotoxin alpha antibody light chain Fab 9606
428 3WD5 2 L Adalimumab Light Chain 9606
429 4NHC 1 L FAB LIGHT CHAIN 9606
430 3EOA 1 A, L Efalizumab Fab fragment, light chain 9606
431 2WUB 4 L, Q FAB FRAGMENT FAB40.DELTATRP LIGHT CHAIN 9606
432 3U46 2 B, L CH02 Light chain Fab 9606
433 4KY1 1 L IMMUNOGLOBULIN IGG1 FAB, LIGHT CHAIN muHP1/2 CDRs + human kappa B3 germline VL framework 9606
434 1ZLW 1 K, L FAB 2G12, light chain FAB, Light Chain 9606
435 4HFU 4 L Fab 8M2 light chain 9606
436 4FP8 3 L, M, N, O Antibody C05, light chain 9606
437 4YPG 1 A, L Sifalimumab light chain 9606
438 3BE1 3 L Fab Fragment-Light Chain 9606
439 2FJH 2 A, L Fab fragment light chain 9606
440 4K9E 1 L light chain 10090
441 3U4B 2 L CH02 Light chain 9606
442 3P0V 1 L, M Fab DL11 light chain 9606
443 2OQJ 1 A, D, G, J Fab 2G12 light chain 9606
444 4FZ8 2 L FAB light chain of human ANTI-HIV-1 ENV ANTIBODY C11 9606
445 1U8O 1 A ANTIBODY 2F5 (LIGHT CHAIN) 9606
446 4UTA 3 L, M BROADLY NEUTRALIZING HUMAN ANTIBODY EDE1 C8 LIGHT CHAIN FAB FRAGMENT 9606
447 3HMX 3 L USTEKINUMAB FAB LIGHT CHAIN 9606
448 4KVN 3 L Human IgG Light Chain 9606
449 4KUC 2 D, E mAb6c2 fab-Heavy chain 10090
450 4K7P 1 X antibody rhumAb6 Fab fragment light chain Fab rhumAb6 9606
451 3OB0 1 K, L Fab 2G12, light chain Fab 9606
452 1T04 1 A, C Huzaf Antibody Light Chain The source is engineered human constant and framework regions with CDRs from mouse. 9606
453 3ZTN 4 L FI6V3 ANTIBODY LIGHT CHAIN 9606
454 5DUM 2 L 65C6 Light Chain 9606
455 4I18 1 B, L antibody light chain Fab 10090
456 3KYM 1 A, C, E, G, I, K, M, O Light Chain Li33 IgG2 9606
457 3IDY 3 C, L Fab b13 light chain 9606
458 4OQT 2 L Light Chain of Li81 Fab, kappa 3 9606
459 3IVK 1 B, L Fab light chain man 10090
460 3KYK 2 L Light Chain Li33 IgG1 9606
461 5I19 1 L FAB LIGHT CHAIN 9606
462 5JOF 2 B, D, F, L VRC03 gLV light chain 9606
463 4IRZ 2 L Fab Natalizumab light chain 9606
464 5FEC 2 B, L germline 3BNC60 light chain 9606
465 1RZI 1 A, C, E, G, I, K, M, O Fab 47e light chain 9606
466 5ESV 2 B, D, L CH03 Light Chain 9606
467 2R56 2 L, M IgE Fab Fragment, light chain 9606
468 1ZA6 1 A, C, E, G IGG Light chain 9606
469 4ZS6 1 D, L fab Light Chain 9606
470 4Z5R 2 A, J, L, P, R, T, V, Y anti-IFN-a antibody rontalizumab light chain 9606
471 1U6A 1 L F105 LIGHT CHAIN ANTIGEN-BINDING FRAGMENT, FAB 9606
472 4XBP 1 B, D, F, L 4E10 FAB LIGHT CHAIN 9606
473 1NGW 1 A, L Mature Metal Chelatase Catalytic Antibody, Light chain germline Fab fragment 10090
474 5BZW 1 A 2B3 HIV Antibody light chain EIVLTQSPGTLSLSPGERATLSCRASQSVSAKNLAWYQQKPGQTPRLLMYGVSLRNTGVP DRFSGSGSGTDFTLTISRLEPEDSAVYFCQQYGTSPTFGQGTKVEIKRTVAAPSVFIFPPSDEQLKSGTASVVCLLNNFYPREAKVQWKVDNALQSGNSQESVTEQDSKDSTYSLSSTLTLSKADYEKHKVYACEVTHQGLSSPVTKSFNRGEC 9606
475 5CD3 2 B, D, F, H DRVIA7 Light Chain 9606
476 5CZV 3 L Fab 20350 light chain 9606
477 4P59 3 L MOR09825 Fab fragment light chain 9606
478 5CJO 3 L FAB light chain 10090
479 4LMQ 3 I, L Stromal cell-derived factor 1 9606
480 3N85 2 L Fab37 Light Chain 9606
481 3G6J 3 E, G Fab light chain 9606
482 3HMW 1 L USTEKINUMAB FAB LIGHT CHAIN 9606
483 2QAD 3 C, G anti-HIV-1 antibody 412d light chain FAB, ANTIGEN-BINDING FRAGMENT 9606
484 4DKE 3 L, M FAb1.1 Light Chain 9606
485 5A3I 4 D, H ANTI-HAEMAGGLUTININ HA1 FAB LIGHT CHAIN 9606
486 3DRT 1 A 2F5 Fab' light chain 9606
487 5I17 1 A, L FAB LIGHT CHAIN 9606
488 1U8P 1 A ANTIBODY 2F5 (LIGHT CHAIN) 9606
489 3NFP 2 B, L Light chain of Fab fragment of daclizumab 9606
490 1BEY 1 L CAMPATH-1H ANTIBODY FAB FRAGMENT 9606
491 4R8W 4 L Light chain of neutralizing antibody CT149 9606
492 1I9R 3 L, M, Y IMMUNOGLOBULIN L 9606
493 4NRY 1 B, L m66 Heavy Chain 9606
494 4XMK 1 L, M, N Light chain of HIV-1 gp120 V3-specific human monoclonal antibody 2424 9606
495 3S37 1 L 1121B Fab light chain 10090
496 1PKQ 1 A, F (8-18C5) chimeric Fab, light chain 10090
497 5JXE 2 C, F Pembrolizumab Fab light chain 9606
498 5KZC 3 D, G, L VRC01 Fab light chain 9606
499 4JM2 3 C 17b Light chain Fab 9606
500 1S78 2 C, E Pertuzumab Fab light chain 10090
501 1OP5 1 K, L FAB 2G12, light chain light chain 9606
502 4UV4 2 L FPRO0165 FAB LIGHT CHAIN 9606
503 4NYL 1 B, D, F, L Adalimumab Light Chain 9606
504 5D1Z 1 A, H Y10 Light Chain 9606
505 5D1Z 3 C, E D4-10 Light Chain 9606
506 4XHJ 3 C, G Fab-RC light chain 9606
507 4JDT 3 L Fab light chain NIH45-46 LIGHT CHAIN 9606
508 5HJ3 4 B, F, J, N KZ52 Antibody Fragment 9606
509 4N90 3 E, G, I Fab light chain 9606
510 4UBD 4 D, H, L, P, T, X monoclonal antibody L chain 9606
511 5D1Q 1 A D2-06 Light Chain 9606
512 5D1Q 4 D P5 Light Chain 9606
513 1ZA3 1 A, L Fab-YSd1 light chain Fab light chain 9606
514 3UAJ 3 D, L Light chain, monoclonal antibody 5H2 Fab 9598
515 3EO1 1 A, D, G, J GC-1008 Fab Light Chain 10090
516 3C09 1 B, L Matuzumab Fab Light chain Human/mouse chimeric derivative of mouse monoclonal antibody 425 10090
517 4IOF 3 D, F Fab-bound IDE, light chain 10090
518 5FUO 3 L FAB LIGHT CHAIN 9606
519 4JHW 2 L D25 light chain 9606
520 4HG4 4 K, M, O, Q, S, U, W, Y, z Fab 2G1 light chain 9606
521 3BQU 1 A 2F5 Fab' light chain 9606
522 3ZTJ 4 H, J, L FI6V3 ANTIBODY LIGHT CHAIN 9606
523 4M1C 3 D, F Fab-bound IDE, light chain 9606
524 2JIX 1 A, G, L ABT-007 FAB FRAGMENT 9606
525 3ULV 2 L Fab15 light chain 9606
526 4M7L 2 L 10H10 light chain SEE REMARK 999 10090
527 4S1R 3 L Fab of VRC01 light chain Fab of VRC01 light chain 9606
528 4MXW 5 L, V anti-Lymphotoxin alpha antibody light chain Fab 9606
529 3EGS 1 A 2F5 Fab' light chain 9606
530 5D1X 1 A D4-30 Light Chain 9606
531 5D1X 4 D P5 Light Chain 9606
532 5JW3 4 L MEDI8852 light chain 9606
533 2NZ9 2 C, E AR2 monoclonal antibody light chain 9606
534 3S36 1 L 1121B light chain 10090
535 3DRO 1 A 2F5 Fab light chain 9606
536 5CWS 1 A, G sAB-158 Fab Light Chain 9606
537 5I5K 3 L, Y Eculizumab light chain (variable domain) 9606
538 4S1S 3 L Fab of VRC01 light chain Fab of VRC01 light chain 9606
539 2R0K 2 L antibody light chain of Fab58 9606
540 3CSY 2 B, D, F, H Fab KZ52 light chain light chain 9606
541 5C8J 2 B, D, F, H Antibody fragment, light chain OBTAINED BY PHAGE DISPLAY FROM A LIBRARY OF HUMAN IGG. ANTIBODY FRAGMENT; THE CDRS ARE COMPLETELY SYNTHETIC 9606
542 4R4F 2 L Antibody 2.2c LIGHT CHAIN 9606
543 4G80 3 B, D, F, H fragment antibody light chain 9606
544 3X2D 3 C, G, K, O Fab light chain 9606
545 3JWO 3 L FAB 48D LIGHT CHAIN 9606
546 5CD5 3 D DRVIA7 Fab Light Chain 9606
547 3P11 2 L Fab DL11 light chain 9606
548 3F12 1 A, C M2J1 Fab 9606
549 3B2V 1 L IMC-11F8 FAB Light chain 9606
550 5IGX 3 L germline NIH45-46 light chain 9606
551 3ULU 2 L Fab15 light chain 9606
552 4XI5 3 C Fab-94 light chain 9606
553 3EOB 1 A, L Efalizumab Fab fragment, light chain 9606
554 4Q5Z 3 J, L, N, P, R, T, V, X IDE-bound Fab, light chain 10090
555 4NM8 3 L, M, N Antibody CR8043, Light Chain 9606
556 4XCY 1 B, D, F, I, K, L 4E10 Fab light chain 9606
557 5JW4 4 N, P, T, V, X MEDI8852 light chain 9606
558 5JW4 6 R MEDI8852 light chain 9606
559 2QR0 1 A, E, G, K, M, Q, S, W Fab-Fragment Light Chain 9606
560 2B4C 3 L anti-HIV-1 gp120 immunoglobulin X5 light chain 9606
561 5ESZ 2 B, L CH04 Light Chain 9606
562 4R4N 3 D, G, K, L, O, R, U, X Antibody 2.2c LIGHT CHAIN 9606
563 3EFF 1 A, C FAB 10090
564 3PJS 1 A, C FAB light chain 10090
565 4ZYP 3 L, M, O Motavizumab antibody light chain 10090
566 4ZYP 5 E, G, I AM14 antibody light chain 9606
567 5DWU 4 L Fab - Light Chain 9606
568 5I8H 5 F, H VRC34.01 Fab light chain 9606
569 4RQS 2 C 17b Fab Light Chain 9606
570 4FQR 4 b, d, f, h, j, l, n, p, r, t, v, x Broadly neutralizing antibody C05, light chain 9606
571 4R4H 3 L Antibody 2.2c, Light chain 9606
572 5FHC 5 L Antibody 114 Fab light chain 9606
573 4XMN 6 L Antibody 87 light chain 32630
574 4XMM 8 L Antibody 57 light chain 9606
575 4NHH 1 F, G, K, L, P, Q 2G12 IgG dimer light chain 9606
576 4NHG 2 B, C, F, G, K, L 2G12 IgG dimer light chain 9606
577 5A8H 3 C, I, O FAB OF BROADLY NEUTRALIZING ANTIBODY 17B 9606
578 5A7X 3 C, G, K FAB OF BROADLY NEUTRALIZING ANTIBODY 17B 9606
579 3J70 2 B, N, S monoclonal antibody 17b heavy chain 9606
580 3CM9 3 L, M, N, O Ig alpha-2 chain C region 9606
581 3CHN 1 L, M, N, O Immunoglobulin kappa light chain 9606
582 2QTJ 1 L, M, N, O Kappa light chain IgA1 9606
583 2ESG 1 L, M Immunoglobulin A1 light chain 9606
584 1R70 1 A, C Human IgA2(m1) Light Chain 9606
585 1IGA 2 C, D IGA1 CHAINS A AND B, HEAVY, CHAINS C AND D, LIGHT 9606